from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2531c/-

LFCtreatmentdescriptionclass of inhibitor

0.422

Amikacinug/mL Amikacintranslation

0.113

Cap5-10ug/mL Capreomycintranslation

-0.124

Rox10-50 ug/mL Roxithromycintranslation

0.421

SM2-5 ug/mL Streptomycintranslation

0.518

Tet5-10 ug/mL Tetracyclinetranslation

-2.035

Rif0.2-5ug/mL Rifampicintranscription

-0.751

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.256

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.231

CPZ10-50 ug/mL Chlorpromazinerespiration

2.335

Clofazimine10-13 ug/mL Clofaziminerespiration

0.894

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.489

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.826

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.903

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.194

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.984

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.217

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.028

Nigericin50 uM Nigericinrespiration

-0.390

TRC10-150 ug/mL Triclosanrespiration

1.945

TRZ10-25 ug/mL Thioridazinerespiration

-1.350

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.313

menadione6-10 ug/mL Menadionerespiration

0.144

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.570

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.237

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.027

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.674

NRP_1Non-replicating persistence stage 1dosRassociated

0.461

Amp0.2mg/mL AmpicillincellWall

0.622

Cephalexin20-100 ug/mL CephalexincellWall

0.545

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.307

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.187

EMB10-20 ug/mL EthambutolcellWall

0.497

Eta12-40 ug/mL EthionamidecellWall

0.457

INH0.2-0.4 ug/mL IsoniazidcellWall

0.285

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.210

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.066

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.726

BZA0.12 mg/mL BenzamidearomaticAmides

-0.516

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.070

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.294

H2O24 mM hydrogen peroxideDNAdamaging

0.369

Levo10 ug/mL LevofloxacinDNAdamaging

-0.340

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.981

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.505

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.098

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.100

Antimycin12.5-50 ug/mL Antimycin A?

-0.724

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.313

PA_110-50 ug/mL Antitubercular compound PA-1?

0.342

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.281

PA8240.2-2 ug/mL PA-824?

-1.487

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.153

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.049

Verapamil50 uM Verapamil?

-0.210

mercaptoethanol2 mM 2-Mercaptoethanol?

0.183

methoxatin10-20 ug/mL Methoxatin?